emtricitabine
emtricitabine is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including emtricitabine. Available dosage forms: capsule, powder.
Drug details
- Generic Name
- emtricitabine
- Brand Names
- emtricitabine
- Application Number
- ANDA091168
- Sponsor
- Cipla USA Inc.
- NDC Codes
- 4
- Dosage Forms
- CAPSULE, POWDER
- Routes
- ORAL
- Active Ingredients
- EMTRICITABINE
Indications and Usage
1 INDICATIONS AND USAGE Emtricitabine is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. Emtricitabine, a nucleoside analog HIV-1 reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )